Lv11
30 积分 2022-06-21 加入
警惕“黑天鹅”防范“灰犀牛”--四川大学华西医院安全管理体系化建设经验分享
2小时前
求助中
Secondary Cancers after Chimeric Antigen Receptor T-Cell Therapy
1年前
已完结
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors
1年前
已关闭
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA- 4157 alone in patients with resected solid tumors and in combi‐ nation with pembrolizumab in patients with unresectable solid tumors
1年前
已关闭
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors
1年前
已关闭
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors
1年前
已关闭
A phase I multicenter study to assess the safety, tolerability, and immunogenicity of mRNA-4157 alone in patients with resected solid tumors and in combination with pembrolizumab in patients with unresectable solid tumors
1年前
已关闭
Sustained release of PKR inhibitor C16 from mesoporous silica nanoparticles significantly enhances mRNA translation and anti-tumor vaccination
1年前
已完结
Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways
1年前
已完结
The systemic toxicity of positively charged lipid nanoparticles and the role of Toll-like receptor 4 in immune activation
1年前
已完结
皖公网安备34019202002308
